These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16556690)

  • 1. Dissociation of lung function changes with humoral immunity during inhaled human insulin therapy.
    Teeter JG; Riese RJ
    Am J Respir Crit Care Med; 2006 Jun; 173(11):1194-200. PubMed ID: 16556690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized study to characterize glycemic control and short-term pulmonary function in patients with type 1 diabetes receiving inhaled human insulin (exubera).
    Norwood P; Dumas R; Cefalu W; Yale JF; England R; Riese R; Teeter J
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2211-4. PubMed ID: 17003088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.
    Skyler JS; Hollander PA; Jovanovic L; Klioze S; Krasner A; Riese RJ; Reis J; Schwartz P; Duggan W;
    Diabetes Res Clin Pract; 2008 Nov; 82(2):238-46. PubMed ID: 18824271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial.
    Garg SK; Mathieu C; Rais N; Gao H; Tobian JA; Gates JR; Ferguson JA; Webb DM; Berclaz PY
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S5-S16. PubMed ID: 19772449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.
    Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic study.
    Heise T; Bott S; Tusek C; Stephan JA; Kawabata T; Finco-Kent D; Liu C; Krasner A
    Diabetes Care; 2005 Sep; 28(9):2161-9. PubMed ID: 16123484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial.
    Rosenstock J; Cefalu WT; Hollander PA; Klioze SS; Reis J; Duggan WT
    Diabetes Technol Ther; 2009 Nov; 11(11):697-705. PubMed ID: 19905885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.
    Ceglia L; Lau J; Pittas AG
    Ann Intern Med; 2006 Nov; 145(9):665-75. PubMed ID: 17088580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial.
    Raskin P; Heller S; Honka M; Chang PC; Boss AH; Richardson PC; Amin N
    Diabetes Obes Metab; 2012 Feb; 14(2):163-73. PubMed ID: 21951325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.
    Quattrin T; Bélanger A; Bohannon NJ; Schwartz SL;
    Diabetes Care; 2004 Nov; 27(11):2622-7. PubMed ID: 15504996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.
    Barnett AH; Dreyer M; Lange P; Serdarevic-Pehar M
    Diabetes Care; 2006 Jun; 29(6):1282-7. PubMed ID: 16732009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of long-term immunological and pulmonary safety of inhaled human insulin with up to 24 months of continuous therapy.
    Cefalu WT; Bohannon NJ; Edwin Fineberg S; Teeter JG; Schwartz PF; Reis JM; Krasner AS
    Curr Med Res Opin; 2008 Nov; 24(11):3073-83. PubMed ID: 18828959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trough insulin levels in bronchoalveolar lavage following inhaled human insulin (Exubera) in patients with diabetes mellitus.
    Mendivil CO; Teeter JG; Finch GL; Schwartz PF; Riese RJ; Brain JD
    Diabetes Technol Ther; 2012 Jan; 14(1):50-8. PubMed ID: 21875362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
    Mathieu C
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of AIR inhaled insulin compared to insulin lispro in patients with type 1 diabetes mellitus in a 6-month, randomized, noninferiority trial.
    Comulada AL; Renard E; Nakano M; Rais N; Mao X; Webb DM; Milicevic Z
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S17-25. PubMed ID: 19772445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive therapy with inhaled insulin via the AERx insulin diabetes management system: a 12-week proof-of-concept trial in patients with type 2 diabetes.
    Hermansen K; Rönnemaa T; Petersen AH; Bellaire S; Adamson U
    Diabetes Care; 2004 Jan; 27(1):162-7. PubMed ID: 14693983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Inhaled Human Insulin (Exu hera
    White NH; Quattrin T; Aubin LBS; Duggan WT; England RD; Fryburg JS
    J Pediatr Endocrinol Metab; 2020 Oct; 21(6):555-568. PubMed ID: 33600687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled insulin: a novel and non-invasive way for insulin administration?
    Quattrin T
    Curr Drug Saf; 2006 May; 1(2):151-8. PubMed ID: 18690926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of AIR inhaled insulin compared with subcutaneous insulin in patients having diabetes and asthma: A 12-month, randomized, noninferiority trial.
    Ang E; Lawrence MK; Heilmann CR; Ferguson JA; Tobian JA; Webb DM; Berclaz PY
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S35-44. PubMed ID: 19772447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perspectives of inhaled insulin treatment].
    Chodorowski Z; Sein Anand J
    Przegl Lek; 2007; 64(4-5):365-7. PubMed ID: 17724916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.